Primary |
Drug Use For Unknown Indication |
50.0% |
Deep Vein Thrombosis |
16.7% |
Thrombosis Prophylaxis |
16.7% |
Acute Coronary Syndrome |
5.6% |
Pulmonary Arterial Hypertension |
5.6% |
Systemic Lupus Erythematosus |
5.6% |
|
Pneumonia Aspiration |
20.0% |
Intestinal Ischaemia |
10.0% |
Spinal Compression Fracture |
10.0% |
Thrombocytopenia |
10.0% |
Cardiac Failure |
5.0% |
Deep Vein Thrombosis |
5.0% |
Legionella Infection |
5.0% |
Oxygen Saturation Decreased |
5.0% |
Pulmonary Embolism |
5.0% |
Sepsis |
5.0% |
Septic Shock |
5.0% |
Sinus Tachycardia |
5.0% |
Vena Cava Thrombosis |
5.0% |
White Blood Cell Count Decreased |
5.0% |
|
Secondary |
Drug Use For Unknown Indication |
53.3% |
Anticoagulant Therapy |
13.3% |
Diffuse Large B-cell Lymphoma |
7.5% |
Product Used For Unknown Indication |
6.7% |
Deep Vein Thrombosis |
5.5% |
Antiplatelet Therapy |
2.4% |
Multiple Myeloma |
2.0% |
Colon Cancer |
1.6% |
Small Cell Lung Cancer Extensive Stage |
1.6% |
Thrombosis Prophylaxis |
1.6% |
Atrial Fibrillation |
1.2% |
Left Ventricular Failure |
1.2% |
Small Cell Lung Cancer Stage Unspecified |
0.8% |
Crohn's Disease |
0.4% |
Lower Respiratory Tract Infection |
0.4% |
Pneumonia Aspiration |
0.4% |
Toxic Epidermal Necrolysis |
0.4% |
|
Pneumonia Aspiration |
14.5% |
Toxic Epidermal Necrolysis |
14.5% |
Intestinal Ischaemia |
9.7% |
Motor Dysfunction |
9.7% |
Cardiac Failure |
4.8% |
Legionella Infection |
4.8% |
Neurolysis |
4.8% |
Paraesthesia |
4.8% |
Septic Shock |
4.8% |
Thrombosis |
4.8% |
Cerebrovascular Accident |
3.2% |
Deep Vein Thrombosis |
3.2% |
Pulmonary Embolism |
3.2% |
Squamous Cell Carcinoma Of Skin |
3.2% |
Cerebral Haemorrhage |
1.6% |
Haematoma |
1.6% |
Haemoglobin Decreased |
1.6% |
Haemoptysis |
1.6% |
Large Intestinal Obstruction |
1.6% |
Optic Disc Haemorrhage |
1.6% |
|
Concomitant |
Drug Use For Unknown Indication |
25.4% |
Product Used For Unknown Indication |
23.9% |
Pain |
7.3% |
Prophylaxis Of Nausea And Vomiting |
6.5% |
Prophylaxis |
5.8% |
Hypertension |
4.4% |
Constipation |
3.8% |
Breast Cancer |
3.1% |
Multiple Myeloma |
2.5% |
Thrombosis Prophylaxis |
2.2% |
Deep Vein Thrombosis |
2.0% |
Nausea |
1.9% |
Prostate Cancer Metastatic |
1.9% |
Pulmonary Embolism |
1.8% |
Atrial Fibrillation |
1.6% |
Anticoagulant Therapy |
1.4% |
Infection |
1.2% |
Ovarian Cancer |
1.1% |
Plasma Cell Myeloma |
1.1% |
Non-small Cell Lung Cancer |
1.0% |
|
Pulmonary Embolism |
16.0% |
Febrile Neutropenia |
9.2% |
Pain |
5.9% |
Pneumonia |
5.9% |
Death |
5.0% |
Spinal Fracture |
5.0% |
Thrombocytopenia |
5.0% |
Vomiting |
5.0% |
Neutropenia |
4.2% |
Neutropenic Sepsis |
4.2% |
White Blood Cell Count Decreased |
4.2% |
Duodenal Ulcer |
3.4% |
Intestinal Anastomosis Complication |
3.4% |
Malignant Neoplasm Progression |
3.4% |
Oesophageal Candidiasis |
3.4% |
Off Label Use |
3.4% |
Pancytopenia |
3.4% |
Polyarthritis |
3.4% |
Spinal Cord Compression |
3.4% |
Tetany |
3.4% |
|
Interacting |
Drug Use For Unknown Indication |
58.3% |
Deep Vein Thrombosis |
16.7% |
Immunodeficiency |
8.3% |
Pain |
8.3% |
Pulmonary Embolism |
8.3% |
|
|